Emodiafiltrazione con reinfusione endogena (HFR).

Translated title of the contribution: [Hemodiafiltration with endogenous reinfusion].

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The dialysis population continues to increase in age and also the number of comorbidities is on the rise in this population. Replacement therapy techniques need to take these clinical challenges into account. Hemofiltrate reinfusion (HFR) is a type of hemodiafiltration where the replacement fluid consists of ultrafiltrate from the patient regenerated through a cartridge containing hydrophobic styrene resin. HFR may offer a good compromise between the optimization of toxin removal and the possible loss of beneficial physiological substances. Patients with a high comorbidity rate benefit in terms of reduced inflammation and improved nutrition. Moreover, the recent development of HFR Aequilibrium, a dialysis technique based on the combination of HFR with dialysate Na+ and UF profiles, has proved to be effective in stabilizing the intradialytic hemodynamics and to be a useful tool in the dialysis routine. HFR appears to be a useful technique for patients with complex risk factors such as malnutrition, inflammation and atherosclerosis.

Original languageItalian
JournalGiornale italiano di nefrologia : organo ufficiale della Società italiana di nefrologia
Volume29 Suppl 55
Publication statusPublished - May 2012

Fingerprint

Hemodiafiltration
Dialysis
Comorbidity
Inflammation
Styrene
Dialysis Solutions
Malnutrition
Population
Atherosclerosis
Hemodynamics
Therapeutics

ASJC Scopus subject areas

  • Nephrology

Cite this

@article{5d47975d40364df79a3b4d7b1aa1efad,
title = "Emodiafiltrazione con reinfusione endogena (HFR).",
abstract = "The dialysis population continues to increase in age and also the number of comorbidities is on the rise in this population. Replacement therapy techniques need to take these clinical challenges into account. Hemofiltrate reinfusion (HFR) is a type of hemodiafiltration where the replacement fluid consists of ultrafiltrate from the patient regenerated through a cartridge containing hydrophobic styrene resin. HFR may offer a good compromise between the optimization of toxin removal and the possible loss of beneficial physiological substances. Patients with a high comorbidity rate benefit in terms of reduced inflammation and improved nutrition. Moreover, the recent development of HFR Aequilibrium, a dialysis technique based on the combination of HFR with dialysate Na+ and UF profiles, has proved to be effective in stabilizing the intradialytic hemodynamics and to be a useful tool in the dialysis routine. HFR appears to be a useful technique for patients with complex risk factors such as malnutrition, inflammation and atherosclerosis.",
author = "Filippo Aucella",
year = "2012",
month = "5",
language = "Italian",
volume = "29 Suppl 55",
journal = "Giornale italiano di nefrologia : organo ufficiale della Società italiana di nefrologia",
issn = "0393-5590",
publisher = "Wichtig Publishing Srl",

}

TY - JOUR

T1 - Emodiafiltrazione con reinfusione endogena (HFR).

AU - Aucella, Filippo

PY - 2012/5

Y1 - 2012/5

N2 - The dialysis population continues to increase in age and also the number of comorbidities is on the rise in this population. Replacement therapy techniques need to take these clinical challenges into account. Hemofiltrate reinfusion (HFR) is a type of hemodiafiltration where the replacement fluid consists of ultrafiltrate from the patient regenerated through a cartridge containing hydrophobic styrene resin. HFR may offer a good compromise between the optimization of toxin removal and the possible loss of beneficial physiological substances. Patients with a high comorbidity rate benefit in terms of reduced inflammation and improved nutrition. Moreover, the recent development of HFR Aequilibrium, a dialysis technique based on the combination of HFR with dialysate Na+ and UF profiles, has proved to be effective in stabilizing the intradialytic hemodynamics and to be a useful tool in the dialysis routine. HFR appears to be a useful technique for patients with complex risk factors such as malnutrition, inflammation and atherosclerosis.

AB - The dialysis population continues to increase in age and also the number of comorbidities is on the rise in this population. Replacement therapy techniques need to take these clinical challenges into account. Hemofiltrate reinfusion (HFR) is a type of hemodiafiltration where the replacement fluid consists of ultrafiltrate from the patient regenerated through a cartridge containing hydrophobic styrene resin. HFR may offer a good compromise between the optimization of toxin removal and the possible loss of beneficial physiological substances. Patients with a high comorbidity rate benefit in terms of reduced inflammation and improved nutrition. Moreover, the recent development of HFR Aequilibrium, a dialysis technique based on the combination of HFR with dialysate Na+ and UF profiles, has proved to be effective in stabilizing the intradialytic hemodynamics and to be a useful tool in the dialysis routine. HFR appears to be a useful technique for patients with complex risk factors such as malnutrition, inflammation and atherosclerosis.

UR - http://www.scopus.com/inward/record.url?scp=84866791804&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866791804&partnerID=8YFLogxK

M3 - Articolo

VL - 29 Suppl 55

JO - Giornale italiano di nefrologia : organo ufficiale della Società italiana di nefrologia

JF - Giornale italiano di nefrologia : organo ufficiale della Società italiana di nefrologia

SN - 0393-5590

ER -